| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan; and the 2 Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
PURPOSE. Angiotensin II (AII) has been shown to play a role in many vascular diseases. In the study described, the effect of AII on vascular endothelial growth factor (VEGF) expression and related intracellular signaling mechanism was investigated in bovine retinal microcapillary pericytes.
METHODS. Cultured bovine retinal microvascular endothelial cells and pericytes were prepared. VEGF expression was determined by Northern blot analysis and immunoprecipitation assay. Cell proliferation was assessed by DNA content growth assay. Reporter gene studies were performed to identify the AII responsible transcription-activating region of VEGF gene.
RESULTS. Angiotensin II induced a significant increase in VEGF mRNA in a time- and dose-dependent manner. Angiotensin II type I receptor antagonist inhibited this effect. Angiotensin II activates the transcription of VEGF gene without changing the mRNA half-life, and the AII responsible region was found in the 5'-flanking region of the VEGF gene. Angiotensin II also increased the expression of c–fos and c–jun mRNA, and antisense oligonucleotides against c-Fos blocked the AII–induced VEGF mRNA expression. The conditioned media of AII–stimulated pericyte cultures had a growth-promoting effect on endothelial cells, and this effect was inhibited almost completely by VEGF neutralizing antibody.
CONCLUSIONS. These findings suggest that AII might induce angiogenic activity through a paracrine function of VEGF in retinal microvascular cells.
This article has been cited by other articles:
|
|
 |
|
  E. I. Ager, J. Neo, and C. Christophi The renin-angiotensin system and malignancy Carcinogenesis, September 1, 2008; 29(9): 1675 - 1684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. deS. Senanayake, J. Drazba, K. Shadrach, A. Milsted, E. Rungger-Brandle, K. Nishiyama, S.-I. Miura, S. Karnik, J. E. Sears, and J. G. Hollyfield Angiotensin II and Its Receptor Subtypes in the Human Retina Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3301 - 3311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Satofuka, A. Ichihara, N. Nagai, T. Koto, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, H. Itoh, et al. Role of Nonproteolytically Activated Prorenin in Pathologic, but Not Physiologic, Retinal Neovascularization Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 422 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nagai, K. Noda, T. Urano, Y. Kubota, H. Shinoda, T. Koto, K. Shinoda, M. Inoue, T. Shiomi, E. Ikeda, et al. Selective Suppression of Pathologic, but Not Physiologic, Retinal Neovascularization by Blocking the Angiotensin II Type 1 Receptor Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 1078 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fujita, I. Hayashi, S. Yamashina, A. Fukamizu, M. Itoman, and M. Majima Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth Carcinogenesis, February 1, 2005; 26(2): 271 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang, M. Lassila, M. E. Cooper, and Z. Cao Retinal Expression of Vascular Endothelial Growth Factor Is Mediated by Angiotensin Type 1 and Type 2 Receptors Hypertension, February 1, 2004; 43(2): 276 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Watanabe, K. Shibata, F. Kikkawa, H. Kajiyama, K. Ino, A. Hattori, M. Tsujimoto, and S. Mizutani Adipocyte-Derived Leucine Aminopeptidase Suppresses Angiogenesis in Human Endometrial Carcinoma via Renin-Angiotensin System Clin. Cancer Res., December 15, 2003; 9(17): 6497 - 6503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Rizkalla, J. M. Forbes, M. E. Cooper, and Z. Cao Increased Renal Vascular Endothelial Growth Factor and Angiopoietins by Angiotensin II Infusion Is Mediated by Both AT1 and AT2 Receptors J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3061 - 3071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-F. Jasmin, A. Calderone, T.-K. Leung, L. Villeneuve, and J. Dupuis Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan Cardiovasc Res, June 1, 2003; 58(3): 621 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Wilson, B. G. Hobbs, W.-Y. Shen, T. P. Speed, U. Schmidt, C. G. Begley, and P. E. Rakoczy Argon Laser Photocoagulation-Induced Modification of Gene Expression in the Retina Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1426 - 1434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. de Boer, Y. M. Pinto, A. J.H. Suurmeijer, S. Pokharel, E. Scholtens, M. Humler, J. M. Saavedra, F. Boomsma, W. H. van Gilst, and D. J. van Veldhuisen Increased expression of cardiac angiotensin II type 1 (AT1) receptors decreases myocardial microvessel density after experimental myocardial infarction Cardiovasc Res, February 1, 2003; 57(2): 434 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Moravski, S. L. Skinner, A. J. Stubbs, S. Sarlos, D. J. Kelly, M. E. Cooper, R. E. Gilbert, and J. L. Wilkinson-Berka The Renin-Angiotensin System Influences Ocular Endothelial Cell Proliferation in Diabetes: Transgenic and Interventional Studies Am. J. Pathol., January 1, 2003; 162(1): 151 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Mori, T Hikichi, T Nagaoka, J Takahashi, N Kitaya, and A Yoshida Inhibitory effect of losartan, an AT1 angiotensin II receptor antagonist, on increased leucocyte entrapment in retinal microcirculation of diabetic rats Br. J. Ophthalmol., October 1, 2002; 86(10): 1172 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Katada, M. Muramatsu, I. Hayashi, M. Tsutsumi, Y. Konishi, and M. Majima Significance of Vascular Endothelial Cell Growth Factor Up-Regulation Mediated via a Chymase-Angiotensin-Dependent Pathway during Angiogenesis in Hamster Sponge Granulomas J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 949 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sakurai, S. Alam, G. Pagan-Mercado, F. Hickman, J.-Y. Tsai, P. Zelenka, and S. Sato Retinal Capillary Pericyte Proliferation and c-Fos mRNA Induction by Prostaglandin D2 through the cAMP Response Element Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2774 - 2781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ando, T. Nagasaka, M. Nomura, S.-I. Tsukahara, Y. Kotani, S. Toda, Y. Murata, A. Itakura, and S. Mizutani Premenstrual Disappearance of Aminopeptidase A in Endometrial Stromal Cells around Endometrial Spiral Arteries/Arterioles during the Decidual Change J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2303 - 2309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Nadal, G. M. Scicli, L. A. Carbini, and A. G. Scicli Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H739 - H748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Otani, H. Takagi, H. Oh, S. Koyama, and Y. Honda Angiotensin II Induces Expression of the Tie2 Receptor Ligand, Angiopoietin-2, in Bovine Retinal Endothelial Cells Diabetes, April 1, 2001; 50(4): 867 - 875. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
